Hello guys, if you search for Aarti Drugs Share Price Target then this is the perfect article for you. If you are interested in pharma industry shares, this article will help you get more information and future opportunities and market trends. Evaluating the business model and financials of the company will get you more insight into whether investing is worth it or not in the future.
If you want to invest in the Long-run the pharma sector is one of the best options for you. Because due to the population growth and the demand for medicine always keeps increasing. Let’s see an in-depth analysis of Aarti Drugs Share Price Target for 2023, 2024, 2025, 2026, and 2030.
Aarti Drugs Share Price Target 2023, 2024, 2025, 2026, 2030
Aarti Drugs was established in 1984, the company is one of the biggest manufacturers of API, Pharma intermediates, specialty chemicals, and formulations with its wholly-owned subsidiary. The company has more than 50 API molecules and 80 plus finished products. Aarti Drugs currently exports its products to more than 100 countries.
Aarti Drugs Share Price Target 2023
Aarti Drugs is one of the leading manufacturers of API (Active Pharmaceutical Ingredients) which is established in 1984 and headquartered in Mumbai. The company manufacture API, Pharma intermediate, Speciality chemicals, and Product Development.
The company stocks were performing well over the period of time, whether these stocks gave 116.4% return over the 3 years as compared to Nifty 100. We can expect this might increase in the upcoming days. Aarti Drugs Share Price Today is Rs. 365.40 (23-2-2023), this value is 52 weeks low, and last quarter QoQ 2022 Dec company’s performance was not good.
As we compare its previous valuation Aarti drugs are fair value now, its P/B ratio is 3.25, and its P/E ratio is 20.52, so you can expect growth in the upcoming days.
Aarti Drugs Share Price Target 2023: The company is the main manufacturer of some of the chemical ingredients, so you can expect the demand in the market and value of shares in 2023 to be Rs. 430 and the second target is Rs. 445
|First Target Share Value||Rs. 430|
|Second Target Share Value||Rs.445|
Aarti Drugs Share Price Target 2024
Aarti Drug Limited is a small-cap company that has a total market value of Rs. 3,372.49 Cr. If we look at the company’s financial details, the company has a low debt-to-EBITDA ratio of 0.99, Earnings per share value (EPS) is 17.88 which is quite good. The company was given good returns to investors over the period.
The company is generating most of its revenue from its API, so the management decided to diversify its products, which means should not depend on a single product. The company was heavily investing in R&D Department for better and new products for customers.
Aarti Share Price Target 2024: The company is looking forward to becoming the leader in the pharma sector, it has the capability to perform in the global market also, so you can expect the share value in 2024 Rs. 475 and the Second share Price target Rs. 490
|First Target Share Value||Rs. 475|
|Second Target Share Value||Rs. 490|
Aarti Drugs Share Price Target 2025
Aarti Drugs Limited is one of the biggest producers of fluoroquinolones ( Used for bacterial infection), and the World’s largest manufacturer of Tinidazole, Matronidazole. The company has a wide range of products that can export to more than 100 countries, it has a 59% of its market share in the Regulated markets, and 39% in the semi-regulated markets.
The company has big clients like Sun Pharma, Mankind, Cipla, Pzifer, and many leading companies in India and the globe. The company can able to make positive cash flow from its operations. Aarti Drugs are looking for reliable Generic bulk actives, advanced intermediates, and specialty chemicals production on a larger scale in the upcoming days.
Aarti Drugs Share Price Target 2025: The company has a strong base in financials and looking forward to expanding its business and production of different products, so you can expect a share value of Rs. 520, and the second target is Rs. 540
|First Target Share Value||Rs. 520|
|Second Target Share Value||Rs. 540|
Aarti Drugs Share Price Target 2026
Aarti Drugs are heavily investing in the expansion of production capacity and looking forward to garb future opportunities, they had the plan to produce their own raw material instead of importing from China. If this process was successfully implemented by the company it can effectively reduce its cost and be able to compete with the global market.
Aarti Drugs Share Price Target 2026 If the company can able to reduce its operating cost its shares may perform better in the future, so as you can see the market value of the pharma industry is booming and it keeps increasing in the future. The share price target in 2026 is Rs. 600 and the second target price is Rs. 630
|First Target Share Value||Rs. 540|
|Second Target Share Value||Rs. 560|
Aart Drugs Share Price Target 2030
Aarti Drugs shares gave extraordinary returns in past years, its annual revenue growth is 16% which is outstanding, and its ROE is 19%, the company has a 13% of debt or equity which means a healthy financial result. According to the report Indian Pharma industry is expecting of CAGR 10.7% growth after COVID.
As Indian Pharma Industry says by 2030 pharma industry can reach $130 bn and India is exporting pharma products to more than 200 countries around the globe. Due to the immense amount of demand and growth potential, you can definitely see good results in the upcoming days.
Aarti Drugs Share Price Target 2030: The company keeps investing in’s R&D and looking for expansion of its manufacturing capacity to utilize the future opportunity, you can expect these shares may give you excellent returns by 2030. The Share Price Target by 2030 is Rs. 900 and the second target is Rs.960
|First Target Share Value||Rs.900|
|Second Target Share Value||Rs.960|
About Of Aarti Drugs
|Industry||Manufacturing Of Active Pharmaceutical Ingredients [APIs], Pharma Intermediates, especially Chemicals|
|Founder Name||Shri Prakash M. Patil|
|Number Of Employees||225|
Aarti Drugs Business Model
Aarti Drugs Limited is one of the leading Indian Pharma companies which mainly manufactures Active Pharmaceutical Ingredients (API) and intermediates. The company involves research and development and manufacturing of pharma products for various therapeutic segments. Aarti Drugs produce a wide range of products like
- APIs- Aarti Drugs makes more than 400 APIs for various therapeutic segments.
- Intermediates – The company manufacture 150+ intermediates
- Speciality Chemicals – Aarti Drugs also produce Speciality chemicals that use for agrochemicals, pigments, and beauty products.
Aarti has a wide range of customer base where they export their products to more than 100+ countries around the world, they had a strong focus on quality and on-time delivery to maintain them in a good position in the industry
Strengths Of Aarti Drugs
- The company is a Zero promoter of Pledge Company
- FPI/FII or companies increase their Holdings
- The company’s revenue growth in the last 3 years is good at 15.70%
- The Company’s profit growth in the previous 3 years is good at 30.75%
- The Company has maintained a healthy ROE of 25.65% over the last 3 Years
- The company has an interest coverage ratio of 11.05
- The company has a very healthy cash conversion cycle of 80.90 days
- The company has maintained an excellent ROCE of 25.20% in the last 3 years
Weaknesses Of Aarti Drugs
- Cash Flow From Operations has been declining sharply for the past 2 years
- Quarterly net profit margin declines [Yoy]
- The Priced below are long-term and medium-term averages
- The company has too many competitors
- The company has regulatory issues
Competitors Of Aarti Drugs
- Pharmaceuticals & Welcure Drugs
- Wanbury Ltd.
- Vivimed Labs Ltd.
- Vivanza Biosciences Ltd.
- Vista Pharmaceuticals Ltd.
- Vikram Thermo Ltd.
- Venues Remedies Ltd.
Aarti Drugs Product Profile
- Products Under Developments
- Pharma Intermediate
- Specialty Chemicals
Shareholding Pattern Of Aarti Drugs
|Holder’s Name||Percentage %|
|No Of Shares||100. %|
|Foreign Institutions||1.9 %|
|N Banks Mutual Funds||3.82 %|
|General Public||25.98 %|
|Financial Institutions||0.8 %|
Aarti Drugs Share Price Target 2023, 2024, 2025, 2026, 2030
|Years||First Target||Second Target|
|||Rs. 430||Rs. 445|
|||Rs. 475||Rs. 490|
|||Rs. 520||Rs. 540|
|||Rs. 600||Rs. 630|
|||Rs. 900||Rs. 960|
If we can see India is becoming the leader in producing pharma products, many leading companies across the globe are interested to buy products from Indian companies due to the low-cost production. So there is growth potential in the pharma sector. Hope after reading this article you can get more information on Aarti Drugs Share Price Target.
The Company management and its business structure are looking good, hope it gave new heights in the upcoming days for its investors. If you like this article Aarti Drigs Share Price Target 2023, 2024, 2025, 2026, and 2030 share it with your friends.
This article is only for educational purposes and no investment advice was given in this article, before investing do your own research or seek advice from your financial advisor. We are not SEBI-registered advisors. The value mentioned here is only for reference purposes.
Is Aarti Drugs a good buy now?
The Price of the company is likely to fall while it is also likely to grow to check the valuation and quality before investing
Is Aarti surfactants a good buy?
On analysis, the company is currently weak and the price of the company is likely to fall in the short term
Who is the promoter of Aarti Drugs?
Shri Prakash M. [Chairman Managing Director & CEO]
What is the old name of Aarti Industries?
Aarti Organics Ltd. The company was incorporated on 28th September 1984 as Aarti Organics Limited